DD284024A5 - Verfahren zum herstellen von o hoch 2 tief ,2'-anhydro-1-(beta-d-arabinofuranosyl)thymin - Google Patents

Verfahren zum herstellen von o hoch 2 tief ,2'-anhydro-1-(beta-d-arabinofuranosyl)thymin Download PDF

Info

Publication number
DD284024A5
DD284024A5 DD89330684A DD33068489A DD284024A5 DD 284024 A5 DD284024 A5 DD 284024A5 DD 89330684 A DD89330684 A DD 89330684A DD 33068489 A DD33068489 A DD 33068489A DD 284024 A5 DD284024 A5 DD 284024A5
Authority
DD
German Democratic Republic
Prior art keywords
hydrogen
alkyl
arabinofuranosyl
anhydro
phenyl
Prior art date
Application number
DD89330684A
Other languages
German (de)
English (en)
Inventor
Charles W Murtiashaw
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD284024A5 publication Critical patent/DD284024A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/09Pyrimidine radicals with arabinosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD89330684A 1988-07-12 1989-07-11 Verfahren zum herstellen von o hoch 2 tief ,2'-anhydro-1-(beta-d-arabinofuranosyl)thymin DD284024A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/217,906 US5008384A (en) 1988-07-12 1988-07-12 Process for the production of O.sup. 2,2'-anhydro-1-(β-D-arabinofuranosyl)thymine

Publications (1)

Publication Number Publication Date
DD284024A5 true DD284024A5 (de) 1990-10-31

Family

ID=22812966

Family Applications (2)

Application Number Title Priority Date Filing Date
DD89330684A DD284024A5 (de) 1988-07-12 1989-07-11 Verfahren zum herstellen von o hoch 2 tief ,2'-anhydro-1-(beta-d-arabinofuranosyl)thymin
DD89337873A DD292003A5 (de) 1988-07-12 1989-07-11 Verfahren zum herstellen von 2-amino-oxazolin-verbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD89337873A DD292003A5 (de) 1988-07-12 1989-07-11 Verfahren zum herstellen von 2-amino-oxazolin-verbindungen

Country Status (21)

Country Link
US (1) US5008384A (el)
EP (1) EP0351126B1 (el)
JP (1) JPH075626B2 (el)
KR (1) KR910008112B1 (el)
CN (1) CN1039423A (el)
AT (1) ATE117314T1 (el)
AU (1) AU603042B2 (el)
CA (1) CA1315776C (el)
DD (2) DD284024A5 (el)
DE (1) DE68920648T2 (el)
DK (1) DK342189A (el)
ES (1) ES2066853T3 (el)
FI (1) FI893364A (el)
GR (1) GR3015293T3 (el)
HU (1) HUT50843A (el)
IE (1) IE65735B1 (el)
IL (1) IL90884A0 (el)
NO (1) NO892821L (el)
PT (1) PT91113B (el)
YU (1) YU138789A (el)
ZA (1) ZA895259B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3065350B2 (ja) * 1990-11-30 2000-07-17 ヤマサ醤油株式会社 1―(2,3―ジデオキシ―β―D―グリセロ―ペント―2―エノフラノシル)チミンの製造法
DE69415506T2 (de) * 1994-05-20 1999-08-12 Council Of Scientific And Industrial Research, New Delhi Verfahren zur Herstellung von Beta-Thymidine
US7125983B2 (en) 2000-11-29 2006-10-24 Mitsui Chemicals, Inc. L-nucleic acid derivatives and process for the synthesis thereof
BR0208517A (pt) * 2001-03-30 2005-02-01 Triangle Pharmaceuticals Inc Processo para a preparação de nucleosìdeos de 2'-halo-sg(b) l-arabinofuranosila
DE10216426A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Verfahren zur Herstellung von beta-L-2'Deoxy-Thymidin
WO2004096149A2 (en) 2003-04-28 2004-11-11 Idenix (Cayman) Limited Industrially scalable nucleoside synthesis
EP1639121A4 (en) 2003-06-30 2008-04-16 Idenix Cayman Ltd SYNTHESIS OF BETA-L-2-DESOXYNUCLEOSIDES
CA2643748A1 (en) 2006-03-15 2007-09-20 Novartis Ag Process for preparing l-nucleic acid derivatives and intermediates thereof
EP2265274B1 (en) 2008-03-03 2018-11-21 Tosk, Inc. Methotrexate adjuvants to reduce toxicity and methods for using the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322747A (en) * 1965-04-01 1967-05-30 Merck & Co Inc Thionocarbonate nucleosides
US3463850A (en) * 1967-01-03 1969-08-26 Merck & Co Inc Arabinofuranosyl 2-thiopyrimidines and pharmaceutical compositions thereof
US3658788A (en) * 1969-06-06 1972-04-25 Salk Inst For Biological Studi Aminooxazolines and products thereof and processes for synthesizing same
US3792040A (en) * 1970-03-19 1974-02-12 Syntex Corp Acyl derivatives of o2,2'-anhydro-1-(beta-d-arabinofuranosyl)-cytosines and methods of preparing
US3812098A (en) * 1970-03-19 1974-05-21 Syntex Inc O2,2'-anhydro-1-(beta-d-arabinofuranosyl)-cytosine derivatives and methods of making and related procedures
US3709874A (en) * 1970-03-19 1973-01-09 Syntex Corp 1-beta-d-arabinofuranosyl cytosine derivatives and methods of preparing
US3920630A (en) * 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
SE391183B (sv) * 1971-04-15 1977-02-07 Asahi Chemical Ind 2',3'-0-sulfinylcytidin och syraadditionssalter derav till anvendning som mellanprodukt for framstellning av 2,2'-anhydro-(1-beta-d-arabinofuranosyl) cytosin
US3978042A (en) * 1975-01-31 1976-08-31 The Upjohn Company Process for preparing cyclocytidine derivatives
US4140850A (en) * 1977-08-29 1979-02-20 The Upjohn Company 2,2'-Anhydrotriazine nucleosides and process for preparing the same
JPS5649398A (en) * 1979-09-28 1981-05-02 Yamasa Shoyu Co Ltd Preparation of 1-beta-d-arabinofuranosyl-2,2'-cyclothymine
JPS636557A (ja) * 1986-06-26 1988-01-12 Sharp Corp 微細パタ−ン形成方法

Also Published As

Publication number Publication date
PT91113A (pt) 1990-02-08
ATE117314T1 (de) 1995-02-15
KR910008112B1 (ko) 1991-10-10
DK342189D0 (da) 1989-07-11
HUT50843A (en) 1990-03-28
IE892233L (en) 1990-01-12
EP0351126B1 (en) 1995-01-18
NO892821D0 (no) 1989-07-07
DD292003A5 (de) 1991-07-18
US5008384A (en) 1991-04-16
EP0351126A2 (en) 1990-01-17
PT91113B (pt) 1995-01-31
DK342189A (da) 1990-01-15
CA1315776C (en) 1993-04-06
GR3015293T3 (en) 1995-06-30
IE65735B1 (en) 1995-11-15
FI893364A0 (fi) 1989-07-11
AU603042B2 (en) 1990-11-01
DE68920648D1 (de) 1995-03-02
YU138789A (en) 1990-12-31
AU3802089A (en) 1990-04-26
ZA895259B (en) 1991-02-27
KR900001704A (ko) 1990-02-27
ES2066853T3 (es) 1995-03-16
IL90884A0 (en) 1990-02-09
JPH075626B2 (ja) 1995-01-25
FI893364A (fi) 1990-01-13
EP0351126A3 (en) 1990-10-24
DE68920648T2 (de) 1995-05-18
NO892821L (no) 1990-01-15
CN1039423A (zh) 1990-02-07
JPH0259598A (ja) 1990-02-28

Similar Documents

Publication Publication Date Title
DE69104312T2 (de) Verfahren zur Herstellung von Hydroxyamiden.
DE3036390A1 (de) Neue pyrrolo-pyrimidine, verfahren zu ihrer herstellung und ihre verwendung bei der herstellung von biologischen wirkstoffen
DE69022176T2 (de) Zwischenverbindung für 2-alkynyladenosinherstellung, herstellung dieser zwischenverbindung, herstellung von 2-alkynyladenosin aus diesem zwischenprodukt sowie stabiles 2-alkynyladenosinderivat.
DE69229492T2 (de) Verfahren zur Herstellung von azyklischen Nukleosiden
DE69109482T2 (de) Pyrimidinnucleosidderivat.
EP0003229A1 (de) Neues Verfahren zur Herstellung von Nucleosiden
EP0056265A2 (de) 5'-Ester von Pyrimidinnucleosiden mit antiviraler Wirksamkeit, Verfahren zur Herstellung und daraus hergestellte Arzneimittel
DE68920648T2 (de) Verfahren zur Herstellung von O2,2'-anhydro-1-(beta-D-arabinofuranosyl)Thymin.
DE2845435A1 (de) Verfahren zur herstellung von 2,6-diaminonebularinen
DE69019052T2 (de) Verfahren zur Herstellung von 2'Deoxy-5-trifluoromethyl-ss-uridin.
DE69027084T2 (de) Verfahren zur Herstellung von Purinverbindungen
DE60114098T2 (de) Ein Verfahren zur Herstellung von Trifluorothymidinderivaten
DE69623117T2 (de) Verfahren zur herstellung von 4-hydroxy-2-pyrrolidon
CH518950A (de) Verfahren zur Herstellung von Nucleosid-phosphaten
DE2409675A1 (de) Alpha-alkyl(oder -aryl)-thio-5-hydroxytryptophan-derivat und verfahren zu seiner herstellung
DE3941657A1 (de) Verfahren zur herstellung von 2-acylamino-6-halogen-purin aus 2,9-diacylguanin
DE60101312T2 (de) Verfahren zur herstellung von indolopyrrolocarbazol-derivaten, deren zwischenprodukte sowie verfahren zur herstellung der zwischenprodukte
DE69507778T2 (de) 2-Aminobenzenesulfosäure- und 2-Aminobenzenesulfonylchloridderivate, ihre Herstellung und ihre Verwendung als Zwischenprodukte für Synthese
EP0062068B1 (en) N-phthalidyl-5-fluorouracil derivatives
DE2707404C3 (de) Verfahren zur Herstellung von 5,6-Dehydropenicillinen
DE2621645C3 (de) Verfahren zur Herstellung von Aminoderivaten von N-Heterocyclen
DE1943428C3 (de) Verfahren zur Herstellung von Pyrimidin- und 6-Azauracilnueleosiden
DE69127238T2 (de) Verfahren zur Herstellung von Pyrido[1,2-a]pyrimidinderivaten
DE68922900T2 (de) Verfahren zur Herstellung von 2'-Deoxy-beta-adenosin.
WO1993011144A1 (de) Neues verfahren zur herstellung von 2-fluorpurin-derivaten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee